XDR-TB in South Africa: Revised definition [2]

PLoS Medicine

Volumn 4, Issue 4, 2007, Pages 770-

  Holtz, Timothy H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

CAUSE OF DEATH; DRUG SENSITIVITY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MYCOBACTERIUM TUBERCULOSIS; NOMENCLATURE; NONHUMAN; PUBLIC HEALTH SERVICE; PUBLICATION; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; ISOLATION AND PURIFICATION; METHODOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; PATIENT CARE; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; MYCOBACTERIUM TUBERCULOSIS; PATIENT ISOLATION; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED STATES;

EID: 34247530802     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040161     Document Type: Letter

References (6)

1. Singh JA, Upshur R, Padayatchi N (2007) XDR-TB in South Africa: No time for denial or complacency. PLoS Med 4: e50. doi:10.1371/journal.pmed.0040050
2. Shah NS, Wright A, Drobniewski F, et al. (2005) Extreme drug resistance in tuberculosis (XDR-TB): Global survey of supranational reference laboratories for Mycobacterium tuberculosis with resistance to second-line drugs. Int J Tuberc Lung Dis 9 (Suppl 1): S77.
3. Holtz TH, Riektsina V, Zarovska E, Laserson KF, Wells CD, et al. (2005) XDR-TB: Extreme drug-resistance and treatment outcome under DOTSPlus, Latvia, 2000-2002. Int J Tuberc Lung Dis 9 (Suppl 1): S258.
4. Moll A, Gandhi NR, Pawinski R, Andrews J, Zeller K, et al. (2006) Identification of a multidrug-resistant tuberculosis cluster as a cause of death among HIV coinfected patients in rural South Africa. 13th Conference on Retroviruses and Opportunistic Infections; 7 February 2006; Denver, Colorado, United States of America. Poster O-115.
5. Centers for Disease Control and Prevention (CDC) (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - Worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 55: 301-305.
6. Centers for Disease Control and Prevention (CDC) (2006) Notice to readers: Revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 55: 1176.